05 Mar Publication of data showing Zorevunersen effects on Dravet Syndrome patients
Stoke Therapeutics, a biotechnology company that works on a proposed...
Stoke Therapeutics, a biotechnology company that works on a proposed...
Dravet Syndrome, a rare epilepsy disorder, hides deeper challenges, and...
The first pan-European meeting on Preclinical Research in Dravet Syndrome,...
We are excited to announce the upcoming Dravet Preclinical Research...
In this video, Dr Gaia Colasante summarizes the strategies and...
In the video above, Dr Massimo Mantegazza, the coordinator of...
The project SCN1A-UP!, coordinated by Dr Massimo Mantegazza and funded...
The development of more effective support systems and an enhanced...